Covalent Interface-Engineered Bone-Targeting Piezoelectric Heterojunction Reprograms Tumor Stress Adaptation and Reverses the Immunosuppressive Microenvironment
ACS Nano · 13.11.2026
DOI: 10.1021/acsnano.6c15131 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 13.11.2026. Verfasst von Jie Wang und 8 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Zhongnan Hospital of Wuhan University.
Abstract (Originalsprache)
Breast cancer bone metastasis remains a major therapeutic challenge due to endoplasmic reticulum stress (ERS)-associated stress adaptation and an immunosuppressive tumor immune microenvironment (TIME). Herein, we report a zoledronic acid (ZOL)-loaded bone-targeted covalent piezoelectric heterojunction nanoplatform (Z@BT-P) for sonopiezo-dynamic therapy (SPDT) and immune remodeling. In this platform, barium titanate (BTO) was covalently integrated with a porphyrinic porous coordination network to form a stable BT-P heterointerface, while ZOL enhanced bone-metastatic lesion enrichment. Compared with physically assembled BT@P, Z@BT-P promoted interfacial charge utilization and strengthened ultrasound (US)-triggered piezoelectric catalysis. Under US irradiation, enhanced charge utilization and Piezo1-associated mechanosensitive Ca2+ signaling jointly amplified reactive oxygen species accumulation and Ca2+ dysregulation, causing dual oxidative/Ca2+ stress. This stress cascade promoted ERS associated with glucose-regulated protein 78 and C/EBP homologous protein, leading to apoptosis and immunogenic cell death. Consequent damage-associated molecular patterns release and ZOL-containing treatment enhanced dendritic cell maturation, drove M1-like macrophage remodeling, and activated antitumor immunity. In a 4T1-luc tibial bone metastasis model, Z@BT-P + US achieved 89.4% ± 4.9% tumor growth inhibition, alleviated osteolytic bone destruction, suppressed distant metastasis, and promoted immune memory. This study establishes a covalent interface-engineered piezoelectric nanoplatform for bone metastasis therapy.
Förderung
- Zhongnan Hospital of Wuhan University
Zitieren
APA
Wang, J., Zhu, G., Ding, Y., Lei, M., Yan, X., Lei, Q., Hu, S., Cai, L., & Yan, F. (2026). Covalent Interface-Engineered Bone-Targeting Piezoelectric Heterojunction Reprograms Tumor Stress Adaptation and Reverses the Immunosuppressive Microenvironment. ACS Nano. https://doi.org/10.1021/acsnano.6c15131
Vancouver
Wang J, Zhu G, Ding Y, Lei M, Yan X, Lei Q, et al. Covalent Interface-Engineered Bone-Targeting Piezoelectric Heterojunction Reprograms Tumor Stress Adaptation and Reverses the Immunosuppressive Microenvironment. ACS Nano. 2026. doi:10.1021/acsnano.6c15131
BibTeX
@article{Wang2026,
author = {Wang, Jie and Zhu, Guangting and Ding, Yunxiang and Lei, Ming and Yan, Xuan and Lei, Qingjian and Hu, Sang and Cai, Lin and Yan, Feifei},
title = {Covalent Interface-Engineered Bone-Targeting Piezoelectric Heterojunction Reprograms Tumor Stress Adaptation and Reverses the Immunosuppressive Microenvironment},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.6c15131}
}
EUVIMED